16 May 2008

Editorial: Routine blood pressure lowering in type 2 diabetes: the ADVANCE trial
By: Carl Erik Mogensen
The results from the blood pressure arm of the ADVANCE trial have recently been published, and a forthcoming presentation at the 68th Scientific Sessions of the American Diabetes Association in San Francisco will reveal data from the blood glucose-lowering arm. Carl Erik Mogensen provides a timely discussion of the importance of this trial for the treatment of patients with type 2 diabetes and a high risk of cardiovascular events.

14 April 2008

Editorial: HIV and the heart: A hidden opportunity
By: Nick Boon
HIV-related heart disease is common but frequently overlooked. Nick Boon, from the University of Edinburgh, UK, discusses the cardiovascular problems associated with HIV/AIDS.

15 February 2008

Editorial: Back to the future: reflections on the Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH) trial
By: Tiny Jaarsma and Dirk J van Veldhuisen
The final results of the COACH study were surprising. However, in their Key Opinion article, Tiny Jaarsma and Dirk J van Veldhuisen discuss the reasons why these results shouldn't lead us to abandon the concept of disease management programs for heart failure.